1. 疾病领域
  2. 癌症 呼吸系统疾病
  3. 肺癌 呼吸系统癌症
  4. 肺鳞状细胞癌

Lung Squamous Cell Carcinoma  (肺鳞状细胞癌)

肺鳞状细胞癌,又称表皮样癌,是一种非小细胞肺癌,起源于气道内壁薄而扁平的细胞,约占所有肺癌的30%。它通常发生于肺中央气道,是非小细胞肺癌的主要亚型之一,与腺癌和大细胞癌并列。虽然早期可能无症状,但常见症状包括咳嗽、胸痛、体重减轻和疲劳;如果癌症扩散到肺部以外,则可能导致吞咽困难或呼吸急促。非小细胞肺癌约占所有肺癌病例的85%,这凸显了鳞状细胞癌在这一群体中的重要性。

Lung squamous cell carcinoma, also known as epidermoid carcinoma, is a type of non-small-cell lung cancer that arises from the thin, flat cells lining the airways, accounting for approximately 30% of all lung cancers. It typically develops in the central air passages of the lungs and is one of the major subtypes of non-small-cell lung cancer, alongside adenocarcinoma and large cell carcinoma. While early stages may be asymptomatic, common symptoms include coughing, chest pain, weight loss, and fatigue; if the cancer spreads beyond the lungs, it may cause difficulty swallowing or shortness of breath. Non-small-cell lung cancers represent about 85% of all lung cancer cases, highlighting the significance of squamous cell carcinoma within this group.

Lung Squamous Cell Carcinoma (3):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-17394
    Cisplatin

    顺铂

    15663-27-1 99.84%
    Cisplatin (CDDP) 是一种抗肿瘤的化疗剂,它与 DNA 交联引起癌细胞中 DNA 损伤。Cisplatin 可激活铁死亡 (ferroptosis) 并诱导自噬 (autophagy)。
    Cisplatin
  • HY-B0015
    Paclitaxel

    紫杉醇

    33069-62-4 99.97%
    Paclitaxel 是一种天然抗肿瘤药,可稳定微管蛋白 (tubulin) 的聚合。Paclitaxel 可导致有丝分裂停滞和诱导细胞凋亡 (apoptosis),最终导致细胞死亡。Paclitaxel 还可诱导细胞自噬 (autophagy)。
    Paclitaxel
  • HY-P9906
    Bevacizumab

    贝伐珠单抗

    216974-75-3 ≥99.0%
    Bevacizumab 是一种人源化的 IgG1 单克隆抗体,高亲和力且特异性地与所有 VEGF-A 结合。
    Bevacizumab